SMi’s 3D Cell Culture conference 2022 – Speakers announced

SMi Reports: Agenda and speaker overview of the upcoming 5th Annual 3D Cell Culture Conference.

LONDON, GREATER LONDON, UNITED KINGDOM, October 26, 2021 /EINPresswire.com/ — SMi Group is delighted to announce the return of the successful 3D Cell Culture Conference for its 5th year, taking place on 9th and 10th February 2022 in London, UK. Over the past few years, 3D Cell Culture has gained momentum within the pharmaceutical industry due to the benefits that this model offers for in vitro applications patient-derived tissues, drug discovery, predictivity and validation, and safety and toxicity.

The two-day agenda will focus on ‘Developing Complex, Translatable and Physiologically-Relevant Celluar Models in Vitro’ which will explore advances application in 3C cell models, microphysiological systems, applications of technology and case studies, imaging, high throughput screening and advances in 3D cell culture models which make up core components within the 3D Cell Culture field.

This year, the conference will be co-chaired by Stefan Przyborski, Professor of Cell Technology, Durham university and Philip Hewitt, Global Head of Early Investigative Toxicology, Merck and proudly sponsored by CELVIVO and Promego.

For those interested in attending, can register at http://www.3D-cellculture.com/EINPR1 , early bird offer save £400 expires 29 October 2021

Guest Speaker: Suzanne Fitzpatrick, Senior Advisor for Toxicology, FDA

Industry and Pharma Speakers:
• Hansjoerg Keller, Sr Principal Scientist, Novartis IBR
• BanuPriya Sridharan, Investigator, Organoid and Cell Biology, GSK
• Caroline Archer, Associate Principal Scientist, AstraZeneca
• Freddy Van Goethem, Scientific Director – Fellow, Johnson & Johnson; Janssen
• Jason Ekert, Senior Director and Head of Complex In Vitro Models, GSK
• Julian Bahr, Senior Scientist, AstraZeneca
• Terry Van Vleet, Investigative Toxicology and Pathology, AbbVie
• Dr. Luca Frenguelli, Senior Scientist, Engitix therapeutics
• Robert Vries, CEO, Hubrecht organoid technology

3D Cell Culture Expert Speakers Include:
• Pedro Pinto, Lab lead, Urology, university of Greifswald – Medical Centre
• Dr. Elisa Budyn, Professor, Mechanical Engineering, Ecole Normale Supérieure Paris-Saclay
• louis Scampavia, Scientific Director, Sr, Scripps
• Catherine Vickers, Head of innovation, nC3Rs
• Stephen J. Fey, Founder and Chief Research Officer, CelVivo
• Anne Rios, Principal Investigator/ Head of the PMC imaging Center, the Princess Maxima Center

In addition to the agenda, there will be two pre-conference interactive workshops on 8th October 2022:

Workshop A: Reducing attrition in drug discovery through the use of human translational cellular models
Workshop Leader: Wendy Rowan, Scientific Director, Novel Human Genetics, GSK

Workshop B: Bioprinting for 3D Cell Culture
Workshop Leader: Kenny Dalgarno, Professor of Manufacturing Engineering, Newcastle University

The conference offers a great opportunity to hear from key profiles and industry leaders, where attendees can learn and explore case studies of 3D cell culture from leading pharma companies to benchmark against their applications of 3D cell technology. The conference also provides insight about the latest technology advances allowing 3D bioprinting to revolutionize in vitro models. Finally, attendees can network with the key industry players developing the use of bioprinting as part of their R&D.

Key Benefits of Attending:
• Discuss the uses of advanced cell technologies to construct in vitro models of human tissues
• Explore the regulatory sciences surrounding Microphysiological systems, and their development and adoption for drug safety assessment
• Uncover the major benefits of 3D modelling in enhancing clinical translation and predictability
• Utilise 3D cell culture for High Throughput drug discovery and Content screening over traditional 2D methods
• Delve into advanced case studies looking into organ models: from organotypic lungs to liver spheroids

The full agenda and speaker line-up are available in the download brochure online at http://www.3D-cellculture.com/EINPR1

For sponsorship enquiries contact Alia Malick on +44 (0)20 7827 6164 or amalick@smi-online.co.uk

For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6162 or ssapal@smi-online.co.uk

3D Cell Culture 2022
Workshops: 8 February 2022
Conference: 9-10 February 2022
Virtual Conference: Online Access Only
http://www.3D-cellculture.com/EINPR1
#SMi3DCellCulture

— ENDS –
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Mrs Simi Sapal
SMi Group
+44 2078276000
email us here


Source: EIN Presswire

U.S. International Development Finance Corporation and Medical Credit Fund Announce Effort to Improve Maternal Health

Postnatal care in Kenya  - mother with nurse

Maternal Health Care, Kenya

Mother and baby in clinic in Kenya PharmAccess

Maternal Health Care, Kenya

Mother and baby in Clinic at Githogoro Clinic Nairobi Kenya

Maternal Health Care at Clinic Githogoro Nairobi Kenya

The New Effort Aims to Improve Maternal Health Care in Sub-Saharan Africa

DFC is proud to support this groundbreaking technical assistance facility, which will help save the lives of low-income mothers and children throughout Africa”

— Algene Sajery, U.S. International Development Finance Corporation (DFC)

AMSTERDAM, NETHERLANDS, October 26, 2021 /EINPresswire.com/ — U.S. International Development Finance Corporation (DFC) and Medical Credit Fund, a non-profit organization established as part of PharmAccess Group, announced today a new collaboration aimed at reducing maternal mortality in Sub-Saharan Africa. This collaboration will result in the design and implementation of a technical assistance facility for health providers in the region, serving mothers and their families in low-income settings. The effort will be supported through the MOMs (Maternal Outcomes Matter) Initiative, a program launched in June 2019 by DFC, MSD for Mothers, Credit Suisse and USAID to mobilize private capital to stimulate, advance and scale innovations that contribute to a healthy pregnancy and safe childbirth in Sub-Saharan Africa and South Asia.

In Sub-Saharan Africa, 200,000 women die each year from causes related to pregnancy, accounting for over two-thirds of all maternal deaths per year worldwide. With adequate care, most of these deaths are preventable. Leveraging more than a decade of combined experience from DFC and Medical Credit Fund in developing innovative health system solutions, this new project will allow hundreds of staff members of African health care facilities to receive in-depth technical support to improve health care services, especially around maternal, newborn, and child health care (MNCH).

The technical assistance facility will combine digitally enabled clinical and strategic learning tools with traditional capacity building, such as on-site trainings. Where applicable, facilities can access loans to finance maternal health quality improvements. The collaboration will also support the implementation of the online Quality Platform from PharmAccess Group’s SafeCare, a standards-based, digital quality improvement platform. Through the online Quality Platform, providers will receive direct guidance and can monitor progress in real-time. The technical assistance facility will subsequently become available for other facilities serving the wider health care community, including public sector health care facilities.

‘’With this collaboration we can lay the basis of an effective model for sustainable technical assistance programs. By introducing online and offline learning programs we can help health care staff to grow and provide better maternal care to their community,’’ said Nicole Spieker, director quality, CEO of PharmAccess as of November 1st.

“Through the MOMs Initiative, MSD for Mothers is thrilled to help catalyze a health care community that is better equipped with the knowledge and skills needed to foster a culture of quality for mothers in Sub-Saharan Africa,” said Dr. Mary-Ann Etiebet, lead of MSD for Mothers, MSD’s global initiative to help create a world where no woman has to die while giving life.

“DFC is proud to support this groundbreaking technical assistance facility, which will help save the lives of low-income mothers and children throughout Africa and enable the development of healthier, more prosperous communities,” said Algene Sajery, DFC’s Vice President of the Office of External Affairs and Head of Global Gender Equity Initiatives.

DFC and Medical Credit Fund take a holistic approach to address the challenges of the private health sector. This new effort builds on their legacy of interventions intended to improve health systems – by promoting safe, high-quality, respectful maternity care for people everywhere, providing access to capital for providers to grow and improve and introducing certified standards for care.

—End of this release—

About the MOMs Initiative
The MOMs (Maternal Outcomes Matter) Initiative, launched in June 2019, brings together the U.S. International Development Finance Corporation (DFC), Merck for Mothers, USAID, and Credit Suisse with the goal of mobilizing up to USD $50M in funding to support private sector companies working to improve maternal health in regions of the world with high rates of maternal death. Initiative partners are also providing technical assistant to investees to ensure they have capacity to meet financial and operational goals as well as impact goals.

About DFC
U.S. International Development Finance Corporation (DFC) is America’s development bank. DFC partners with the private sector to finance solutions to the most critical challenges facing the developing world today. We invest across sectors including energy, healthcare, critical infrastructure, and technology. DFC also provides financing for small businesses and women entrepreneurs in order to create jobs in emerging markets. DFC investments adhere to high standards and respect the environment, human rights, and worker rights.
Contact:
press@dfc.gov

About Medical Credit Fund
Established in 2009 as part of the PharmAccess Group, the Medical Credit Fund (MCF) is the only not-for profit fund exclusively dedicated to financing small and medium-sized healthcare companies (health SMEs) in Africa. MCF is a blended fund that works with a wide network of African partners to provide SMEs with loans and technical assistance so they can expand their businesses and invest in quality improvement. MCF uses innovative financing solutions and digital technologies to cater to the financing needs of health SMEs and help achieve the Sustainable Development Goals for health.
Contact:
j.boersma@pharmaccess.org
+31638428089

About PharmAccess
PharmAccess believes in doing healthcare better. With a focus on sub-Saharan Africa, PharmAccess is an international NGO that works on improving healthcare markets so that they can deliver for everyone. Its work has long focused on achieving greater health access, echoing the global call for universal health coverage, by mobilizing private and public resources, measuring and improving quality of services, and reaching even the most excluded people with financing options to pay for care.
Contact:
j.boersma@pharmaccess.org
+31638428089

Jeltsje Boersma
PharmAccess
+31202103920
j.boersma@pharmaccess.org
Visit us on social media:
Twitter
LinkedIn


Source: EIN Presswire

Polycystic Ovary Syndrome Market, 2021-2031 – Roots Analysis

Polycystic Ovarian Syndrome (PCOS)

Polycystic Ovarian Syndrome (PCOS)

Polycystic Ovarian Syndrome (PCOS) - Roots Analysis

Polycystic Ovarian Syndrome (PCOS) – Roots Analysis

Polycystic Ovarian Syndrome - Roots Analysis

Polycystic Ovarian Syndrome – Roots Analysis

Roots Analysis logo

Roots Analysis logo

Polycystic Ovary Syndrome Market, 2021-2031 – Roots Analysis

LONDON, ENGLAND, UNITED KINGDOM, October 26, 2021 /EINPresswire.com/ — Polycystic ovary syndrome affects 1 in 10 women of childbearing age. The exact cause of the condition is unknown; however, obesity, high levels of inflammation and insulin resistance are the common risk factors

Roots Analysis is pleased to announce the publication of its recent study, titled, “Polycystic Ovary Syndrome Market, 2021-2031.”

The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:
 A detailed assessment of the therapeutic pipeline activity and therapeutic assessment of the products.
 Detailed profiles of the players that are engaged in the development of drug products / therapies for polycystic ovarian syndrome.
 An insightful market assessment summary, highlighting the clinical and commercial attractiveness of pipeline molecules (phase II and phase III).
 A detailed analysis identifying the key opinion leaders (KOLs), featuring a 2X2 analysis to assess the relative experience of certain KOLs.
 An insightful analysis of the patents filed / granted for polycystic ovary syndrome, since 2016, taking into consideration various parameters.
 An in-depth analysis of grants awarded to various research institutes for the projects related to polycystic ovary syndrome, in the period between 2016 and April 2021.
 A detailed analysis of completed, ongoing and planned clinical studies, based on the various relevant parameters.
 A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
 Drug Class
 Insulin Sensitizing Agents
 Oral Contraceptives
 Anti-Androgens
 Anti-Obesity
 Route of Administration
 Oral
 Subcutaneous
 Intravenous
 Others
 Regional Distribution
 North America (US, Canada)
 Europe (France, Germany, Italy, Spain, UK)
 Asia-Pacific and Rest of the World (Australia, China, India and Japan)

Key companies covered in the report
 AbbVie
 Bayer
 GlaxoSmithKline
 Lupin Pharmaceuticals
 Merck
 Pfizer
 Takeda
 Teva Pharmaceuticals

For more information please click on the following link:
https://www.rootsanalysis.com/reports/polycystic-ovarian-syndrome-market.html

Other Recent Offerings
1. Non-hormonal Therapies for Women’s Health Market, 2021-2030
2. Squamous Non-Small Cell Lung Cancer: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031
3. Vascular Disrupting Agents Market, 2021-2030

About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com

Gaurav Chaudhary
Roots Analysis
+1 415-800-3415
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Diabetic Care Market Size, Business Opportunities By Leading Players, Development, Acquisition and Pricing Analysis

Emergen Research Logo

Emergen Research Logo

Diabetic Care Market Size – USD 22.70 Billion in 2019, Market Growth – CAGR of 7.9%, Market Trends –

VANCOUVER, BC, CANADA, October 26, 2021 /EINPresswire.com/ — The global Diabetic Care Market will be worth USD 41.71 billion by 2027, according to a current analysis by Emergen Research. The report gathers viable information on the most established industry players, sales and distribution channels, regional spectrum, estimated market share and size, and revenue estimations over the forecast timeframe. There has been a potential increase within the incidents of polygenic disease on a global scale, as a result of the rising level of inactive lifestyles and obesity in the global population. The submarkets like analogues and human insulin are likely to keep up dominance throughout the global diabetic treatment market.

The report emphasizes the demands and ongoing trends of the global Diabetic Care market, more importantly, across the major regions of the market. Additionally, our analysts have included SWOT analysis and Porter’s Five Forces analysis in the report to offer a better understanding of the competitive spectrum of this ever-evolving industry. The study performs a historical assessment of the Diabetic Care from 2017 to 2018, focusing on the market trends, revenue share, growth rate, production capacity, pricing structure, and other vital aspects during that period. The report sheds light on the mergers and acquisitions, collaborations, joint ventures, brand promotions and product launches, agreements and partnerships, and corporate and government deals.

Increase in the emergence of type 1 and type 2 diabetes, is anticipated to fuel the diabetes care market. Additionally, the event of the development of type 1 and type 2 diabetic treatments are likely to stay profitable for pharmaceutical firms in the mid-to-long term. An incentive for less affluent patients particularly in the developing economies, reductions in price and technological innovations are the major factors driving the diabetes treatment market growth. Moreover, the diabetic treatment market has a well thought out R&D pipeline.

To get a sample copy of the Global Diabetic Care Market report, visit @ https://www.emergenresearch.com/request-sample/180

With the accelerating usage of anti-diabetics, drug manufacturers across the globe can open up opportunities to manage various disorders related to metabolism, thereby benefitting both the healthcare providers and patients. Additionally, medications that are meant to target long term weight reduction and other related conditions is in demand, owing to the cases of type 2 diabetes.

Key Highlights From The Report.
The products required to treat diabetes extends to injectable diabetes drugs, , insulin therapies, blood glucose monitoring systems, insulin pumps, oral drugs, and insulin injection devices. Additionally, a significant quantity of emerging diabetic drugs is under clinical observation by potentially large pharmaceutical organizations that are likely to get a traction in the market over the forecasted period..

Lifescan, a US based diagnostic systems manufacturer made a partnership agreement with DKSH in January 2020. Through this partnership, they’ll provide sales, regulatory and marketing services for LifeScan products in Asian countries like Vietnam, Indonesia, Philippines, Hong Kong, Malaysia and Taiwan. DKSH will also support the distribution and logistic side of the business in addition to the above mentioned services.
The global Diabetic Care market consists of various segments, including product type outlook, application spectrum, end-user overview, leading regions, and the competitive analysis. The report further provides information regarding the value chain, emerging market sectors, and the technological advancements in the industry to benefit readers and businesses looking to invest in this industry.

Key Market Competitors Profiled in the Report:
Medtronic plc, B. Braun, DexCom, Inc., Abbott, F. Hoffman-La Roche Ltd., Ascensia Diabetes Care Holdings AS, LifeScan, Dickinson and Company, MicroGene Diagnostic Systems Pvt. Ltd., AgaMatrix Holdings LLC and Acon Laboratories, Inc. among others.

The latest report offers a profound analysis of the present market scenario, its key product types, end-user landscape, application outlook, leading regions, competitive terrain, and the leading companies’ detailed profiles. The study performs a historical assessment of the Diabetic Care from 2017 to 2018, focusing on the market trends, revenue share, growth rate, production capacity, pricing structure, and other vital aspects during that period. The report sheds light on the mergers and acquisitions, collaborations, joint ventures, brand promotions and product launches, agreements and partnerships, and corporate and government deals.

To learn more details about the Global Diabetic Care Market report, visit @ https://www.emergenresearch.com/industry-report/diabetic-care-market

The global Diabetic Care market report evaluates the latest economic scenario in terms of value and volume. It highlights the key growth drivers, restraints, production capacity, demand & supply ratio, import/export status, growth rate, and other critical aspects. Additionally, the report also performs SWOT analysis, Porter’s Five Forces analysis, speculation attainability investigation, and venture return investigation.

Global Diabetic Care Market Geographical Landscape – Synopsis:

The report closely studies the growth trajectory of the global Diabetic Care market. It brings to light the global dominance of the leading regional segments, including North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa.

The study elaborates on the crucial information pertaining to the regional market share. It simultaneously focuses on the significant details about the growth patterns of each regional market.

Moreover, the report encases an exhaustive geographical study of the market, emphasizing the business growth prospects and market barriers for each of the key market regions.
For the purpose of this report, Emergen Research has segmented into the global Diabetic Care Market on the device, distribution channel & end user:

Device Outlook (Revenue, USD Billion; 2017-2027)
Monitoring Devices
Insulin Pumps
Insulin Syringes
Insulin Cartridges
Disposable Pens
Jet Injectors

Distribution Channel Outlook (Revenue, USD Billion; 2017-2027)
Hospital Pharmacies
Retail Pharmacies
Diabetes Clinics
Online Pharmacies
Others

End User Outlook (Revenue, USD Billion; 2017-2027)
Hospitals
Homecare
Diagnostic Centers

Proceed To Buy: https://www.emergenresearch.com/select-license/180

Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique

Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027

Chapter 3. Key Insights

Chapter 4. Diabetic Care Market Segmentation & Impact Analysis
4.1. Diabetic Care Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Growing prevalence of diabetes and its increasing awareness
4.2.2.2. Rising geriatric population on a global scale
4.2.3. Market restraints analysis
4.2.3.1. Lack of stringent regulations and reimbursements in specific countries
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis

Chapter 5. Diabetic Care Market By Devices Insights & Trends, Revenue (USD Million)
5.1. Devices Dynamics & Market Share, 2019 & 2027
5.1.1. Monitoring Devices
5.1.2. Insulin Pumps
5.1.3. Insulin Syringes
5.1.4. Insulin Cartridges
5.1.5. Disposable Pens
5.1.6. Jet Injectors
Continue…

Request customization of the report: https://www.emergenresearch.com/request-for-customization/180

Key Objectives of the Report:
Analysis and estimation of the Diabetic Care market size and share for the projected period of 2020-2027

Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape

Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Diabetic Care market

Global Diabetic Care Market Highlights:
Regional demand estimation and forecast
Product Mix Matrix
R&D Analysis
Cost-Benefit Analysis
Pre-commodity pricing volatility
Supply chain optimization analysis
Technological updates analysis
Raw Material Sourcing Strategy
Competitive Analysis

To get a discount on the Global Diabetic Care Market report, visit @ https://www.emergenresearch.com/request-discount/180

Thank you for reading our report. If you have any requests for customization of the latest report, kindly get in touch with us. Our team will assist you and ensure the report is designed as per your requirements.

Read similar reports by Emergen Research:
RFID in Healthcare Market: https://www.emergenresearch.com/industry-report/rfid-in-healthcare-market

Next-Generation Sequencing Market: https://www.emergenresearch.com/industry-report/next-generation-sequencing-market
Regenerative Medicine Market: https://www.emergenresearch.com/industry-report/regenerative-medicine-market

Patient Engagement Solutions Market: https://www.emergenresearch.com/industry-report/patient-engagement-solutions-market

Molecular Diagnostics Point of Care Market: https://www.emergenresearch.com/industry-report/molecular-diagnostics-point-of-care-market

About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Eric Lee
Emergen Research
+91 90210 91709
sales@emergenresearch.com
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Hospital Linen Supply and Management Services Market Report, Growth, Trends, Outlook 2021-26

Hospital linen Supply and Management Services Market

Hospital linen Supply and Management Services Market

SHERIDAN, ALABAMA, UNITED STATES, October 26, 2021 /EINPresswire.com/ — According to the latest report by IMARC Group, titled ” Hospital linen Supply and Management Services Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-26″, the global hospital linen supply and management services market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 4.1% during 2021-2026.

Hospital linen supply and management services market refer to facilities provided by third-party organizations to ensure proper hygiene of towels, mattresses, screens, curtains, blankets, pillow covers, doctor coats, bedsheets, etc., in medical facilities. These services help in managing clothes and reducing the risk of cross-contamination as compared to the in-house laundry that involves massive installation and maintenance costs.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/hospital-linen-supply-management-services-market/requestsample

Global Hospital linen Supply and Management Services Market Trends:

The escalating demand for advanced healthcare facilities due to the growing prevalence of chronic diseases that require surgical interventions is creating a positive outlook for the global linen supply and management services market. Moreover, with the rising cases of COVID-19, there is a surging need for intensive care unit (ICU) and inpatient beds to treat the infection. This is currently propelling the demand for hospital linen supply and management services.

Besides this, the easy availability of customized non-woven linens that are economical, lightweight, and can be quickly disinfected is also catalyzing the market growth. Several leading market players are also providing value-added services, such as uniform rental and waste removal systems, which will continue to further drive the global market for hospital linen supply and management services in the coming years.

Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/hospital-linen-supply-management-services-market

Global Hospital linen Supply and Management Services Market 2021-2026 Analysis and Segmentation:

Competitive Landscape with Key Player:

Alsco Inc., Aramark
Celtic Linen
Cintas Corporation
Elizabethtown Laundry Company
Emes Textiles Pvt. Ltd.
Healthcare Services Group Inc.
ImageFIRST Healthcare Laundry Specialist
Sobel Westex
STERIS plc.
Tetsudo Linen Service Co. Ltd.
Unitex Textile Rental Services Inc

Market Breakup by Product:

Bed Sheet and Pillow Covers
Blanket
Bed Covers
Bathing and Cleaning Accessories
Patient Repositioner

Market Breakup by Material:

Woven
Non-Woven

Market Breakup by Service Provider:

In-house
Contractual

Market Breakup by End Use:

Hospitals and Clinics
Diagnostic Centers
Others

Market Breakup by Region:

North America
Asia-Pacific
Europe
Latin America
Middle East and Africa.

Key Highlights of the Report:

Market Performance (2015-2020)
Market Outlook (2021- 2026)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Other Report:

Marketing Automation Market: https://www.imarcgroup.com/marketing-automation-market
Virtual Fitting Room Market: https://www.imarcgroup.com/virtual-fitting-room-market
Nurse Call Systems Market: https://www.imarcgroup.com/nurse-call-systems-market
E-Cigarette Market: https://www.imarcgroup.com/e-cigarette-market
Circuit Protection Market: https://www.imarcgroup.com/circuit-protection-market
Hemodynamic Monitoring Market: https://www.imarcgroup.com/hemodynamic-monitoring-market
Oncology Biosimilars Market: https://www.imarcgroup.com/oncology-biosimilars-market
Arthroscopy Devices Market: https://www.imarcgroup.com/arthroscopy-devices-market
Contraceptive Devices Market: https://www.imarcgroup.com/contraceptive-devices-market
Vehicle-To-Grid Market: https://www.imarcgroup.com/vehicle-to-grid-market

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Elena Anderson
IMARC Services Private Limited
+1 631-791-1145
email us here


Source: EIN Presswire

Medical Cannabis Market Demand, Growth, Trend, Business Opportunities, Manufacturers and Research Methodology by 2028

Emergen Research Logo

Emergen Research Logo

Medical Cannabis Market Growth – at a CAGR of 11.5%, Market Trends – Legalization of marijuana in various countries

VANCOUVER, BC, CANADA, October 26, 2021 /EINPresswire.com/ — The global medical cannabis market size is expected to reach USD 24.52 Billion at a steady revenue CAGR of 11.5% in 2028, according to latest analysis by Emergen Research. The Global Medical Cannabis Market Report offers extensive knowledge and information about the Medical Cannabis market pertaining to market size, market share, growth influencing factors, opportunities, and current and emerging trends. The report is formulated with the updated and latest information of the global Medical Cannabis market further validated and verified by the industry experts and professionals. Increase in medical cannabis products and the rise in research activities are driving the market revenue growth. Moreover, legalization of the product in several countries is also propelling growth of the market.

Medical cannabis is deemed safer and has fewer side-effect as compared to other treatment options. It is used to treat nausea and combat negative side-effects, especially among patients undergoing chemotherapy, making the whole procedure more tolerable. Rise in geriatric population is also fueling market growth as older people are more susceptible to illness and experience a high level of pain. Research and development activities, clinical trials, and commercialization of the product will also foster market growth.

The product is used with other opioid painkillers, which permits patients to reduce the dosage and frequency of opioids, relieving pain. Legalization of marijuana throughout the country could create up to 1 million jobs by 2025 in the U.S. Workers are needed to farm, process, distribute and sell marijuana and its related products. Medical cannabis has not only created jobs but have also generated significant amount of taxes. For instance, Colorado, in 2019, collected more than USD 302 million in taxes and fees on medical and recreational marijuana.

To get a sample copy of the Global Medical Cannabis Market report, visit @ https://www.emergenresearch.com/request-sample/174

Some Key Highlights in the Report
In October 2020, MediPharm Labs Corp. signed an exclusive supply agreement with STADA to meet the growing demand for medical cannabis in Germany. STADA wanted to be the go-to partner for generics, which is achieved by the partnership.

Oil segment is expected to register significant growth rate during the forecast period due to high demand for hemp oil among healthcare workers for clinical purposes. Cannabidiol (CBD) oil can reduce depression and anxiety, alleviate cancer-related symptoms, and relieves pain. CBD oil can also treat acne owing to its ability to reduce sebum production and anti-inflammatory properties.

The latest research report by Emergen research, named ‘Global Medical Cannabis Market – Forecast to 2027’, entails a comprehensive review of the global Medical Cannabis market’s present and future trends. The report additionally sheds light on the emerging growth opportunities in the business sphere that are anticipated to bolster the growth of the market. The report sheds light on the mergers and acquisitions, collaborations, joint ventures, brand promotions and product launches, agreements and partnerships, and corporate and government deals.
Top competitors of the Medical Cannabis Market profiled in the report include:
Canopy Growth Corporation, Aphria, Inc., Aurora Cannabis, Maricann Group, Inc., Tilray, Cronos Group, Organigram Holdings, Inc., Vivo Cannabis, Tikun Olam, and Insys Therapeutics, Inc.

To learn more details about the Global Medical Cannabis Market report, visit @ https://www.emergenresearch.com/industry-report/medical-cannabis-market

Additionally, the report provides an extensive analysis of the Medical Cannabis market, including key data, such as factors influencing the growth of the market, buyers and vendors, production and consumption, and revenue. Furthermore, the report provides a comprehensive overview of the Medical Cannabis market along with product portfolio and market performance. The report offers key insights into market share, supply chain analysis, demand and supply ratio, import/export details, and product and consumption patterns. To gain a better understanding, the report is further segmented into sections such as product types offered by the market, application spectrum, companies, and key geographical regions where the market has established its presence.

The report aims to deliver a comprehensive understanding of the Medical Cannabis market growth and expansion in each key region of the world. It offers accurate estimations about the expected market size and growth over the projected timeline of 2020-2027.

Regional Segmentation:
North America
Latin America
Europe
Middle East & Africa
Asia Pacific
Emergen Research has segmented the global Medical Cannabis market on the basis of product type, application, and route of administration, distribution channel, and region:
Product Type Outlook (Revenue, USD Billion; 2018-2028)
Oil
Buds
Tinctures
Application Outlook (Revenue, USD Billion; 2018-2028)
Chronic Pain
Mental Disorders
Anorexia
Seizures
Muscle Spasm
Cancer
Others
Route of Administration Outlook (Revenue, USD Billion; 2018-2028)
Oral
Intravenous
Inhalation
Topical
Distribution Channel Outlook (Revenue, USD Billion; 2018-2028)
Dispensaries
Online
Proceed To Buy: https://www.emergenresearch.com/select-license/174

Key Points Covered in This Section:
Regional contribution
Estimated revenue generation
Vital data and information about the consumption rate in all the leading regional segments
An expected rise in market share
Forecast growth in the overall consumption rate

Table of Content
Table of Content

Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique

Chapter 2. Executive Summary
2.1. Summary Snapshot, 2020-2028

Chapter 3. Key Insights

Chapter 4. Medical Cannabis Market Segmentation & Impact Analysis
4.1. Medical Cannabis Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Growing adoption of medical marijuana for treatment of chronic diseases
4.2.2.2. Growing legalization of medical marijuana in various countries
4.2.3. Market restraints analysis
4.2.3.1. Lower market access of marijuana due to absence of legalization programs
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Chapter 5. Medical Cannabis Market By Product Type Insights & Trends Revenue (USD Million)
5.1. Product Type Dynamics & Market Share, 2021 & 2028
5.1.1. Oil
5.1.2. Buds
5.1.3. Tinctures
Continue…
Key Questions Answered in the Report:
What are the key growth driving and restraining factors of the Medical Cannabis market?
Who are the prominent players operating in the market? What are the key strategies adopted by these companies?
What is the growth rate of the Medical Cannabis market? What is the anticipated market valuation of Medical Cannabis industry by 2027?

Report Highlights:
Besides offering a vivid depiction of the global Medical Cannabis business sphere and its fundamental operations, the latest report provides the industrial chain analysis and list down the current and future market trends and growth opportunities.
The report includes information on the present and historical market scenarios, which helps forecast the market conditions over the next eight years (2020-2027).
The report scrutinizes the salient factors influencing the growth of the market in the near future.

To get a discount on the Global Medical Cannabis Market report, visit @ https://www.emergenresearch.com/request-discount/174

Thank you for reading our report. If you have any requests for customization of the latest report, kindly get in touch with us. Our team will assist you and ensure the report is designed as per your requirements.

Read similar reports by Emergen Research:

Regenerative Medicine Market: https://www.emergenresearch.com/industry-report/regenerative-medicine-market

Patient Engagement Solutions Market: https://www.emergenresearch.com/industry-report/patient-engagement-solutions-market

Molecular Diagnostics Point of Care Market: https://www.emergenresearch.com/industry-report/molecular-diagnostics-point-of-care-market

NGS Sample Preparation Market: https://www.emergenresearch.com/industry-report/nucleic-acid-isolation-and-purification-market

Nucleic Acid Isolation and Purification Market: https://www.emergenresearch.com/industry-report/nucleic-acid-isolation-and-purification-market

Viral Vector and Plasmid Manufacturing Market: https://www.emergenresearch.com/industry-report/viral-vector-and-plasmid-manufacturing-market

About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Eric Lee
Emergen Research
+91 90210 91709
sales@emergenresearch.com
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Analgesics Market Segmentation and Analysis by Latest Trends and Growth by Regional Forecast, 2028

North America accounted for a major share of the overall analgesics market revenue in 2020, owing to large number of pharmaceutical companies in this region

PORTLAND, OREGON, UNITED STATES, October 26, 2021 /EINPresswire.com/ — According to the report by Allied Market Research, titled, "Analgesics Market by Type (Non-opioids, Opioids) and Route of Administration (Oral, Intravenous, Rectal, Transdermal, Topical) – Global Opportunity Analysis and Industry Forecast, 2021 – 2028". The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.

Frequent pain and aches experienced by the ageing population, increasing incidences of cardiovascular disease (CVD), cancer, & arthritis, and rising investments in R&D by the public & private sectors, with key focus on the classes of compounds to formulate new therapeutics, are the major factors boosting the market growth. However, factors such as uncontrolled prescriptions of opioids and drug abuse, leading to approximately 28,000 deaths in the U.S. every year, and insufficient regulatory guidelines, especially against opioid analgesics, are likely to impede the market growth. Furthermore, the increase in popularity of personalized medicine is expected to provide numerous growth opportunities for the analgesics market in the near future.

For Right Perspective and Competitive Insights, Get Sample Report at:

https://www.alliedmarketresearch.com/request-sample/1254

Comprehensive competitive analysis and profiles of major market players, such as

Bayer AG
Novartis AG
GlaxoSmithKline PLC
Pfizer Inc.
Johnson & Johnson
Reckitt Benckiser (RB)
Endo Pharmaceuticals
Bristol-Myers Squibb
Eli Lilly Company
Sanofi

Key Benefits For Stakeholders:

• The study provides an in-depth analysis of the Analgesics Market along with the current trends and future estimations to elucidate the imminent investment pockets.

• It offers Analgesics Market analysis from 2020 to 2028, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.

• A comprehensive analysis of four regions is provided to determine the prevailing opportunities.

• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global Analgesics Market growth.

Table of Contents:

CHAPTER 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO perspective
2.2 Market beyond: what to expect by 2027

2.2.1 Base case scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario…………..

FREQUENTLY ASKED QUESTIONS?

Q1. What is the market value of Analgesics Market report in forecast period?
Q2. What would be forecast period in the market report?
Q3. What is the market value of Analgesics Market in 2020?
Q4. Which is base year calculated in the Analgesics Market report?
Q5. Does the Analgesics Market company is profiled in the report?
Q6. Which are the top companies hold the market share in Analgesics Market?
Q7. Does the Analgesics Market report provides Value Chain Analysis?
Q8. What are the key trends in the Analgesics Market report?

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert:

https://www.alliedmarketresearch.com/purchase-enquiry/1254

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Psoriatic Arthritis Treatment Market – Global Opportunity Analysis and Industry Forecast, 2020–2028

Healthcare CRO Services market – Global Opportunity Analysis and Industry Forecast, 2019-2028

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

David Correa
Allied Analytics LLP
+18007925285 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Cancer Pain Market to Witness Huge Growth by 2030

global Cancer Pain Market generated $6.19 billion in 2020, and is projected to garner $10.32 billion by 2030, witnessing a CAGR of 5.3% from 2021 to 2030.

PORTLAND, OREGON, UNITED STATES, October 26, 2021 /EINPresswire.com/ — According to the report by Allied Market Research, titled, "Cancer Pain Market by Drug Type (Opioids, Non-opioids, and Nerve Blockers), and Disease Indication (Lung Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Blood Cancer, and Others): Global Opportunity Analysis and Industry Forecast, 2021––2030". The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.

Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/5123

Increase in incidence of cancer across the globe and surge in healthcare expenditure drive the growth of the global cancer pain market. However, fatal effects associated with the use of drugs employed in cancer pain management hinder the market growth. On the other hand, surge in number of pipeline drugs and untapped potential in emerging economies present new opportunities in the coming years.

Comprehensive competitive analysis and profiles of major market players, such as

Pharmaceutical Company, Inc.
CK Life Sciences (WEX Pharmaceuticals)
BioDelivery Sciences International, Inc.
Grünenthal Pharma GmbH & Co. KCG
Daiichi Sankyo Co., Ltd.
Mundipharma International Limited
Hisamitsu Pharmaceutical Co., Inc.
Pfizer Inc.
Orexo AB

Based on disease indication, the lung cancer segment held the largest share in 2020, accounting for more than one-fifth of the global cancer pain market, and is estimated to maintain its dominance during the forecast period. However, the breast cancer segment is projected to manifest the fastest CAGR of 6.1% from 2021 to 2030.

Key Benefits For Stakeholders:

• The study provides an in-depth analysis of the Cancer Pain Market along with the current trends and future estimations to elucidate the imminent investment pockets.

• It offers Cancer Pain Market analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.

• A comprehensive analysis of four regions is provided to determine the prevailing opportunities.

• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global Cancer Pain Market growth.

FREQUENTLY ASKED QUESTIONS?

Q1. What is the market value of Cancer Pain Market report in forecast period?
Q2. What would be forecast period in the market report?
Q3. What is the market value of Cancer Pain Market in 2020?
Q4. Which is base year calculated in the Cancer Pain Market report?
Q5. Does the Lab-on-Chip Market company is profiled in the report?
Q6. Which are the top companies hold the market share in Cancer Pain Market?
Q7. Does the Lab-on-Chip Market report provides Value Chain Analysis?
Q8. What are the key trends in the Cancer Pain Market report?

Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Multiple Sclerosis Therapies Market – Global Opportunity Analysis and Industry Forecast, 2020–2028

Intelligent Asthma Monitoring Devices Market – Global Opportunity Analysis and Industry Forecast, 2019-2028

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

David Correa
Allied Analytics LLP
+18007925285 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

The Mesothelioma Options Help Center of Illinois Endorses The Steinberg Law Group as the Best Mesothelioma Law Firm

The asbestos industry knowingly poisoned people for decades.

Pipefitters are at a higher risk of exposure to asbestos than most due to the hands-on nature of the job.

The Steinberg Law Group is affiliated with doctors around the country.

We support our veterans.

Experience/Resources/Results

The Mesothelioma Options Help Center of Illinois Endorses The Steinberg Law Group as the Best Mesothelioma Law Firm – Experience/Resources/Results

SPRINGFIELD, ILLINOIS, USA, October 26, 2021 /EINPresswire.com/ — The Mesothelioma Options Help Center of Illinois is dedicated to providing the best possible legal and medical assistance to those stricken with mesothelioma or asbestos-related lung cancer. Anyone wishing to discuss their legal and/or medical options should call (888) 891-2200 to speak directly with an attorney from The Steinberg Law Group.

The Mesothelioma Options Help Center of Illinois has endorsed The Steinberg Law Group because of their vast experience in handling mesothelioma and other asbestos-related cases. With offices in New York, California and Texas, The Steinberg Law Group has a national footprint that helps win the best possible financial compensation for clients.

Typically, asbestos exposure will have occurred sometime between the 1950s and the 1980s. Some of the most prevalent professions that encountered large quantities of asbestos include power plant workers, maritime workers, industrial workers, plumbers, pipefitters, electricians, mechanics, machinists, miners, railroad workers and construction workers, to name a few. Since the latency period for mesothelioma patients is approximately 40 years, most people diagnosed with mesothelioma or asbestos-related lung cancer in 2021 were exposed decades ago.

Although Illinois has no known naturally occurring asbestos deposits, residents of the state must be weary of the many industries throughout the state that relied heavily on asbestos such as the power generating, manufacturing and oil refining industries. Illinois’ abundance of industries helps explain why the over 350,000 tons of asbestos-contaminated vermiculite from the notorious mine in Libby, Montana were shipped into the state during the twentieth century.

Jobsites and locations with known asbestos exposure in Illinois include, but are not limited to, Illinois Beach State Park, Baldwin Power Plant, Crawford Generating Station, Dresden Generating Station, Emerson Electric Facility, Fisk Generating Station, Zion Nuclear Power Station, Powerton Powerhouse, Chicago Nuclear Powerhouse, Browns Ferry Nuclear Plant, Dixie Square Mall, Magnolia School, Newman School, Milton School, Thebes School, Cairo/Lincoln School, Alton Memorial Hospital, Alton Powerhouse, Alton State Hospital, Gilson Brown School, Godfrey School, Humboldt School, Mark Twain School, North Middle School, Principia College, Anna State Hospital, Copley Memorial Hospital, Great Lakes Forge, Madonna High School, St. Joseph Mercy Hospital, Bartonville Grade School, Belleville Area College, Belleville East High School, Excelsior Foundry, Our Lady Queen of Peace School, Saint Clair County Courthouse, Saint Elizabeth Hospital, Highland Hospital, National Gray Iron Foundry, Franklin Hospital, Illinois State University, Illinois Wesleyan University, Blue Island Forging, Southern Illinois University, Centralia Powerhouse, Herman M. Adler Clinic, University of Illinois, Advocate Sherman Hospital, Air Force High School, Argonne National Laboratory, Chicago National History Museum, Chicago O’Hare International Airport, Chicago Wesley Memorial Hospital, North Park College, Edgewater Hospital, New Chicago Trade School, Mundelein College, Michael Reese Hospital, Loyola University, Kincaid Power Station, Inland Steel Powerhouse, Illinois Institute of Technology and George Williams College.

Known companies with asbestos exposure in Illinois include, but are not limited to, A.E. Staley Manufacturing Company, Dearborn Rubber Corporation, Freeman Coal Company, Kautt & Bux Manufacturing, LTV Steel, Mobil, Pneumo Abex Corporation, Amoco, Shell, Standard, Johns-Manville Corporation, Grundy Industries, Inc., Eureka Company, CITGO, Kentile Floors, Inc., Alton Box Board and Paper Company, Alton Gas and Electric Company, Alton Steam Laundry Company, Alton Steel Company, Alton Water Company, American Smelting, American Water Works & Electric Company, Duncan Foundry and Machine Works, E.W. Clark and Company, Fairbanks and Company, Laclede Steel Company, Owens-Illinois, Russell Miler Milling Company, Sears, Roebuck & Company, Spanks Milling Company, Fruit Growers Refining and Power Company, Union City Tract’N and Power Company, Corn Products Company, CFC International, Aurora Automatic Machine Company, Aurora Paper Board Company, Aurora Street Railway Company, Austin – Western Company, C. E. Refractories, Caterpillar Tractor Company, Commonwealth Edison Company, Consolidated Paper Company, Davis Aurora Company, Fiber Container Corporation, Forty Eight Insulations, Inc., Fox River Light, Heat and Power Company, Independent Pneumatic Tool Company, Lyon Metal Products, M. H. Detrick Company, New Process D-Enameling Company, William F. Jobbins, Inc., Wilker Process Equipment, Inc., Western Wheeled Scraper Company, Western United Gas and Electric Company, Western Austin Company, Thor Power Tool Company, Stephens-Adamson Manufacturing Company, Rathbone, Sard and Company, Dynegy Power Corporation, Illinois Power Company, Reabody Coal Company, Sprinkman Sons Corporation, Illinova Power Marketing, Inc., Allied Mills, Inc., Central Illinois Light Company, Keyston Steel & Wire, Furnsa Electric Company, Metal Dross Corporation, Van Nortwick Paper Company, Western Paper Bag Company, Johnson and Johnson, Minnesota Mining and Manufacturing Company/3M, Viskase Company, Moroney John J. & Company, Carling Brewery, Kenneth Wild Concrete Company, Rust Company, Inc., St. Clair County Gas and Electric Company, Belvidere Distilling Company, Belvidere Screw and Machine Company, Chrysler Corporation, Dean Milk Company, Paulson Heating Company, R and D Thiel, Inc., Shield Ware, Inc., Franklin County Mining Company, Petroff Packing Company, Alton Railroad Company, Archer Daniels Midland Company, Ashland Chemical Company, Beich Candy Company, Bloomington and Normal Railway Electric and Heat Company, Citizens Gas, Light and Heating Company, Consumers Heat and Electric Light Company, Eureka Williams Corporation, Firestone Tire & Rubber Company, Funk Brothers Seed Company, Ma Girl Supply Company, Madison County Light and Power Company, Owens Corning Fiberglass Corporation, Peoria, Bloomington and Champaign Railway Company, Ralston Purina Company, Texas Pipeline Company, Union Asbestos, Unarco, Air Reduction Chemical Company, Calumet Brick Company, Chicago Copper and Chemical Company, Clark Oil & Refining Company, Enterprise Wire Company, Great Lakes Refining Company, Illinois Brick Company, Libby, McNeill & Libby, Inc., Modern Drop Forge Company, North Shore Electric Company, Public Service Company of Northern Illinois, Tuthill Building Material Company, Bunge Corporation, Krolhler Manufacturing Company, Swift & Company, Burkhart Manufacturing Company, Cairo Railway and Light Company, Cairo Water Company, E.L. Bruce Company, Missouri Cotton Oil Company, Singer Manufacturing Company, United Chemical and Organic Products Company, Wilson and Company, Canton Gas and Electric Company, Central Illinois Light Company, International Harvester Company, P and O Manufacturing, Inc., Peoples Gas and Electric Light Company, United Electric Coal Company, Wood Preserving Company, Tri Star Metals, Hollywood Brands, Inc., Illinois Central Railroad Company, Natural Gas Pipeline Company of America, Texas-Illinois Natural Gas Pipe Line Company, Abbott Laboratories, Inc., Clifford-Jacobs Forging Company, Danville Urbana and Champaign Railway, Kraft Foods, Inc., Smith and Company, Urbana and Champaign Street Railway Company, Urbana and Champaign Railway Gas and Electric Company, A. Finkl & Sons Steel, A. H. Andrews & Company, A. H. Ross & Sons Company, A. P. Green Fire Brick Company, Abell Box Corporation, ACandS, Inc., Acme Steel Company, Adahy Packing Company, Admiral Corporation, Advertising Metal Display Company, Aermotor Windmill Company, Aetna Bearing Company, Agar Manufacturing Corporation, Air Products and Chemicals, Inc., Air Reduction Sales Company, Albert Schwill and Company, Allied Chemical & Dye Corporation, Allied Metal Company, Allis Chalmers Company, Alsik Brick Company, America Strawboard Company, American Bank Note Company, American Brake Shoe & Foundry Company, American Bridge Company, American Can Company, American Car & Foundry Company, American Cereal Company, American Coconut Butter Company, American Cutlery Company, American Engineering Company of Mexico, American Furniture Mart Corporation, American Granite Company, American Hide and Leather Company, American Industrial Service Company, American Licorice Company, American Lumber and Treating Company, American Maize-Products Company, American Malting Company, American Molasses Company, American Oil Company, American Radiator Company, American Rolling Mill Company/ARMCO, American Sheet & Tin Plate Company, American Spiral Pipe Company, American Steel and Wire Company, American Steel Foundries, Inc., American Tar Products Company, Ameritech Corporation, Anglo-American Provision Company, Apex Smelting Company, Arcole Midwest Corporation, Argo International Corporation, Armour & Company, Armster Company, Armstrong Brothers Tool Company, Armstrong Cork Company, Arnold Company, Arnold Electric Power Station Company, Asbestos and Magnesia Materials Company, Atchison, Topeka and Santa Fe Railway Company, Atlas Forging Company, Aullman Company, Austin Company, Autopoint Company, B. Brody Heating, Badenoch Brothers, Baltimore & Ohio Railroad Company, Barber Asphalt Paving Company, Barkling Fuel Engineering Company, Barkling Industrial Furnace Corporation, Barrett Manufacturing Company, Bartholomae & Leicht Brewing Company, Bastian-Blessing Company, Batchelder-Beilin Company, Bauerle & Stark Company, Baxter Healthcare Corporation, Beatrice Creamery Company, Beatrice Foods Company, Bedford Stone Quarries Company, Bela Seating Company, Bell Box Corporation, Belmont Radio Corporation, Bemis & McAvoy Brewing Company, Benefit Trust Life Insurance Company, Beneke Corporation, Bishop and Babcock Company, Blackstone Manufacturing Company, Bodine Electric Company, Bonell Manufacturing, Borden, Inc., Borg-Warner Chemical, Bowman Dairy Company, Boyd, Lunham & Company, Brand Insulations, Inc., Braun & Fitts Company, Breuer Electric Manufacturing Company, Brink’s, Inc., Brody Seating Company, Brunswick-Balke-Collender Company, Buick Motor Company, Burny Brothers, Inc., Burton Auto Spring Corporation, Butler Brothers, C. F. Claussen and Sons, C.B. Pride Rhinelander Paper Company, C.D. Cash and Company, C.E. Billin and Company, Cable Company, Calumet Portland Cement Company, Campbell Soup Company, Canal-Randolph Corporation, Cardox Corporation, Cargill, Inc., Carnegie-Illinois Steel Corporation, Carnotite Reduction Company, Carson Pirie Scott & Company, Case and Martin Company, Central Asbestos & Magnesia Company, Central Cold Storage Company, Central Service Company, Central Soya Company, Central States Steel Boiler Company, Central Steel and Wire Company, Champion Laundry, Inc., Charles E. Larson & Sons, Inc., Charles Pope Glucose Company, Chicago & Northwestern Railway Company, Chicago Aerifrom Carbon Company, Chicago and Milwaukee Electric Railway Company, Chicago Bridge & Iron Company, Chicago Carton Company, Chicago City Railway Company, Chicago Coated Board Company, Chicago Cold Storage Company, Chicago Consolidated Traction Company, Chicago Edison Company, Chicago Label & Box Company, Chicago Mill and Lumber Company, Chicago Molded Products Corporation, Chicago Packing Company, Chicago Pipe & Boiler Covering Company, Chicago Pneumatic Tool Company, Chicago Portland Cement Company, Chicago Rawhide Manufacturing Company, Chicago Roller Skate Company, Chicago Southern Railway Company, Chicago Steel & Wire Company, Chicago Sugar Refining Company, Chicago Telephone Company, Chicago Union Station Company, Chicago Union Traction Company, Chicago Union Transfer Railway Company, Chicago, Lake Shores & Eastern Railway Company, Chromium Mining & Smelting Corporation, Clayton Mark and Company, Coca-Cola Bottling Company, Columbia Tool Steel Company, Commercial Stamping & Forging, Congress Hotel Company, Connecticut Mutual Life Insurance Company, Connelly-GPM, Inc., Consolidated S. and W. Company, Consumers Company, Container Corporation of America, Continental Can Company, Continental Illinois National Bank and Trust Company, Cook Chocolate Company, Cooperative Construction Company, Corn Products Manufacturing Company, Corn Products Refining Company, Cornell Forge Company, Cosmopolitan Electric Company, Crane Company, Crerar, Adams & Company, Cribben and Sexton Company, Crystal Pure Candy Company, Culberg Asbestos & Cork Company, Cuneo Press, Inc., Curtiss Candy Company, D. M. Zuary and Company, Daly’s Laundry Company, Dana, Inc., Darling & Company, Deering Harvester Company, Defense Plant Corporation, Derby Steam Laundry Company, Devoe & Raynolds Company, Diamond Alkali Company, Diamond Cement and Lithe Stone Company, Diamond Glue Company, Diamond Match Company, Draper and Kramer, Inc., Drewry’s Limited U. S. A., Inc., Drovers Packing Company, E. J. Brach & Sons, E. J. Davis Manufacturing Company, E. L. Mansure Company, E. L. Prussing & Company, Eagle Grinding Wheel Corporation, Eastman Kodak Company, Eckhart & Swan Milling Company, Economy Plumbing & Heating Company, Edison Electric Appliance Company, Inc., North American Cold Storage Company, North American Asbestos Corporation, NL Industries, Inc., New York Life Insurance Company, New York Central Railroad Company, Neisner Brothers, Nehi Royal Crown Corporation, Natural Gas Storage Company of Illinois, Natural Gas Pipeline Company of America, National Warehouse Corporation, National Video Corpoartion, National Tea Company, National Steel Company, National Safe Deposit Company, National Railway Construction Company, National Parlor Furniture Company, National Malleable & Steel Castings Company, National Laundry & Dry Cleaning Company, National Can Company, National Brick Machine Company, National Box Company, National Baking Company, National Aluminate Corporation, Naico Chemical Company, National Biscuit Company/Nabisco, N. K. Fairbanks Company, Murphy Varnish Company, Multi Electric Manufacturing, Inc., Morris and Company, Morgan Linen Supply, Inc., Montgomery Ward, Inc., Monarch Leather Company, Monarch Laundry & Dry Cleaning Services LLC, Modern Steel & Treat Company, Mills Novelty Company, Miehle Printing Press Manufacturing Company, Midwest Brass Forging Company, Midwesco Enterprises, Inc., Middle West Utilities Company, Mid-West Spring and Stamping, Metropolitan West Side Elevated Railroad Company, Medical Center Steam Company, Mechanics Overall Laundry and Rental Company, Mechanical Rubber Company, Mechanical Finishers, Inc., McWilliams Dredging Company, McCormick Harvesting Machine Company, Material Service Corporation, Masury-Young Company, Mason, Davis and Company, Marworth, Inc., Mars, Inc., Marine and Inland Insurance Company, Marblehead Lime Company, Manz Corporation, Manhattan Brewing Company, Magnaflux Corporation, Magid Glove & Safety Manufacturing Company LLC, M.H. Detrick Company, M. H. Ritzwoller Company, M. C. Bullock Manufacturing Company, Luse-Stevenson Company, Lurie & Company, Louis C. Ehle & Company, Louis Pfaelzer & Sons, Litho-Strip Corporation, Liquid Carbonic Corporation, Link-Belt Company, Linde Air Products Company, Lindberg Engineering Company, Lianco Container Corporation, Lever Brothers Company, Leonard & Son Construction Company, Lehon Company, Lehigh Valley Coal Company, Lanzit Corrugated Box Company, Lanquist & Illsley Company, Lamson & Sessions Company, Lampcraft Industries, Lakeside Central Company, Lake Shore and Michigan Southern Railway Company, L.E. Myers Company, L. H. Prentice Company, L. H. and P. Company, Kroch’s & Brentano’s, Inc., Krapp Forge, Inc., Knickerbocker Ice Company, Kensington Steel Company, Kenney Paper Company, Kailer Youngquist, Inc., K & S Precision Metals, Joslyn Manufacturing & Supply Company, Joseph T. Ryerson & Son, Inc., John Wood Company, John F. Jelke Company, John E. Shulze & Sons, Inc., Jernberg Industries, Jarrow Products Corporation, James Stewart & Company, James S. Kirk & Company, J.W. Sefton Manufacturing Company, J.R. Short Milling, J. C. Deagan, Inc., J & J Tool Company, Iroquois Iron Company, Iowa Valve Company, International Rolling Mills Company, International Paper Company, International Nickel Mining Company, Interlake Steel Corporation, Interlake Iron Corporation, Interlake Coke, Inc., Interchemical Corporation, Inter Ocean Publishing Company, Insulation Construction Company, Inland Steel Company, Industrial Metal Coating & Finishing Company, Indiana Steel Company, Indiana Quarries Company, Independent Packing Company, Illinois Vinegar Manufacturing Company, Illinois Steel Company, Illinois Packing Company, Illinois Meat Company, Illinois Maintenance Company, Illinois Insulation & Construction Company, Illinois Fireproof Covering Company, Illinois Fibre Specialty Company, Illinois Car and Equipment Company, Illinois Brick Company, Illinois Bell Telephone Company, IBM, Hysan Products Company, Hyman-Michaels Company, Hygienic Ice Company, Hydro-Blast, Inc., Hyde Park Electric Light and Power Company, Huron and Orleans Building Corporation, Hunts-Wesson Foods, Inc., Hunt Foods and Industries, Inc., Hudson Engineering & Fabrication, Howard Foundry Corporation, Home Insurance Company, Hoffman-Stafford Tanning Company, Hinde & Dauche Paper Company, Hinckley and Schmitt, Inc., Heick Die Casting Corporation, Harvey Metals Corporation, Hartmann-Sanders Company, Harris Brothers Company, Harold Gunnarson Company, Harish Company, Harmony Company, Harco Aluminum, Hanson Bros. Scale Company, Hansell-Elcock Company, Hanley-Casey Company, Handy Button Realty Corporation, Hammond Organ Company, H. M. Byllesley & Company, Gutmann & Company, Grigsby-Grunow Company, Griffin Wheel Company, Greenlee Brothers & Company, Greenebaum Tanning Company, Great Western Laundry Company, Great Western Cereal Company, Great Lakes Metal Finishing Company, Great Lakes Carbon Corporation, Grabler Manufacturing Company, GPE Controls, Inc., Gottfried Brewing Company, Gordon Baking Company, Goodman Manufacturing Company, Glucose Sugar Refining Company, Globe Roofing Products Company, Globe Laundry Company, Glidden Company, Glasser Crandell Company, Gerts, Lombard & Company, Scott Air Force Base, George B. Swift Company, General Mills, Inc. andGeneral Signal Corporation.

To determine the best possible medical treatment for your mesothelioma or asbestos-related lung cancer, contact The Steinberg Law Group so a member of our team can determine which hospitals and doctors in our network are most convenient for you. For more information about mesothelioma and asbestos-related lung cancer, call (888) 891-2200 or visit www.mesotheliomaoptions.com/contact/ now.

Robert L. Steinberg
The Steinberg Law Group
+1 8888912200
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Cerebrospinal Fluid Management Market Business Opportunities, Competitive Landscape & Analysis Research Report by 2027

Emergen Research Logo

Emergen Research Logo

The rising incidence of hydrocephalus and increasing use of shunting procedures are driving the demand for the market.

VANCOUVER, BC, CANADA, October 26, 2021 /EINPresswire.com/ — The global Cerebrospinal Fluid Management Market is forecasted to be worth USD 2.00 Billion by 2027, according to a current analysis by Emergen Research. The report gathers viable information on the most established industry players, sales and distribution channels, regional spectrum, estimated market share and size, and revenue estimations over the forecast timeframe. The report emphasizes the demands and ongoing trends of the global Cerebrospinal Fluid Management market, more importantly, across the major regions of the market.

The rising prevalence of hydrocephalus among the worldwide population is anticipated to propel the market growth over the forecast period. Since 2000, over 370,000 American service embers have suffered a TBI (traumatic brain injury), one of the factors of hydrocephalus. It is anticipated that 14.0% of those who have had an extreme brain injury cause hydrocephalus. Additionally, our analysts have included SWOT analysis and Porter’s Five Forces analysis in the report to offer a better understanding of the competitive spectrum of this ever-evolving industry.

Besides, the rising incidence of tumors, infectious diseases, and brain hemorrhages among the pediatric population is expected to further drive the market growth. The study performs a historical assessment of the Cerebrospinal Fluid Management from 2017 to 2018, focusing on the market trends, revenue share, growth rate, production capacity, pricing structure, and other vital aspects during that period. The report sheds light on the mergers and acquisitions, collaborations, joint ventures, brand promotions and product launches, agreements and partnerships, and corporate and government deals.

Key Highlights From The Report
In July 2019, Arkis Biosciences Inc. acquired by Integra LifeSciences Corporation. This deal will enhance Integra's position as the global leader in innovative catheter technology and expand its offering for neurocritical care.

The shunts and valve segment is expected to dominate the market with a CAGR of 4.6%, due to this method helps medical practitioners to easily collect cerebrospinal fluid samples.
To get a sample copy of the Global Cerebrospinal Fluid Management Market report, visit @ https://www.emergenresearch.com/request-sample/179

The latest report offers a profound analysis of the present market scenario, its key product types, end-user landscape, application outlook, leading regions, competitive terrain, and the leading companies’ detailed profiles. The treatment of hydrocephalus is a complex process that requires high precision devices to gain the success rate. This has resulted in implementing advanced sensors in cerebrospinal fluid management devices, which is expected to propel the demand for this technology shortly.

The global Cerebrospinal Fluid Management market consists of various segments, including product type outlook, application spectrum, end-user overview, leading regions, and the competitive analysis. The report further provides information regarding the value chain, emerging market sectors, and the technological advancements in the industry to benefit readers and businesses looking to invest in this industry.

Key Market Competitors Profiled in the Report:
Möller Medical GmbH, Elekta AB, Medtronic Plc, B. Braun Melsungen AG, Sophysa SA, BeckerSmith Medical, Inc, Dispomedica GmbH, DePuy Synthes Companies, Spiegelberg GmbH & Co. KG, and Integra LifeSciences Corporation among others.

To learn more details about the Global Cerebrospinal Fluid Management Market report, visit @ https://www.emergenresearch.com/industry-report/cerebrospinal-fluid-management-market

The global Cerebrospinal Fluid Management market report evaluates the latest economic scenario in terms of value and volume. It highlights the key growth drivers, restraints, production capacity, demand & supply ratio, import/export status, growth rate, and other critical aspects. Additionally, the report also performs SWOT analysis, Porter’s Five Forces analysis, speculation attainability investigation, and venture return investigation.

Emergen Research has segmented the global Cerebrospinal Fluid Management Market on the basis of product, patient type, end-use, and region:
Product Outlook (Revenue, USD Billion; 2017-2027)
Critical Care Product
Shunts & Valves
Others

Patient Type Outlook (Revenue, USD Billion; 2017-2027)
Geriatric
Adult
Pediatric

End-Use Outlook (Revenue, USD Billion; 2017-2027)
Clinics
Hospitals
Ambulatory Surgical Centers
Others

Global Cerebrospinal Fluid Management Market Geographical Landscape – Synopsis:

The report closely studies the growth trajectory of the global Cerebrospinal Fluid Management market. It brings to light the global dominance of the leading regional segments, including North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa.

The study elaborates on the crucial information pertaining to the regional market share. It simultaneously focuses on the significant details about the growth patterns of each regional market.

Moreover, the report encases an exhaustive geographical study of the market, emphasizing the business growth prospects and market barriers for each of the key market regions.

Proceed To Buy: https://www.emergenresearch.com/select-license/179

Table of Content

Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique

Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027

Chapter 3. Key Insights

Chapter 4. Cerebrospinal Fluid Management Market Segmentation & Impact Analysis
4.1. Cerebrospinal Fluid Management Market Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. The rise in the number of shunting procedures
4.2.2.2. The increasing incidence of hydrocephalus
4.2.3. Market restraints analysis
4.2.3.1. Problems related to shunts
4.2.3.2. Expensive equipment costs
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis

Chapter 5. Cerebrospinal Fluid Management Market By Product Insights & Trends, Revenue (USD Billion)
5.1. Product Dynamics & Market Share, 2019 & 2027
5.1.1. Critical Care Product
5.1.2. Shunts & Valves
5.1.3. Others
Continue…

Key Objectives of the Report:

Analysis and estimation of the Cerebrospinal Fluid Management market size and share for the projected period of 2020-2027

Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape

Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Cerebrospinal Fluid Management market
Global Cerebrospinal Fluid Management Market Highlights:

Regional demand estimation and forecast
Product Mix Matrix
R&D Analysis
Cost-Benefit Analysis
Pre-commodity pricing volatility
Supply chain optimization analysis
Technological updates analysis
Raw Material Sourcing Strategy
Competitive Analysis
To get a discount on the Global Cerebrospinal Fluid Management Market report, visit @ https://www.emergenresearch.com/request-discount/179

Thank you for reading our report. If you have any requests for customization of the latest report, kindly get in touch with us. Our team will assist you and ensure the report is designed as per your requirements.

Read similar reports by Emergen Research:
RFID in Healthcare Market: https://www.emergenresearch.com/industry-report/rfid-in-healthcare-market
Next-Generation Sequencing Market: https://www.emergenresearch.com/industry-report/next-generation-sequencing-market

Regenerative Medicine Market: https://www.emergenresearch.com/industry-report/regenerative-medicine-market

Patient Engagement Solutions Market: https://www.emergenresearch.com/industry-report/patient-engagement-solutions-market

Molecular Diagnostics Point of Care Market: https://www.emergenresearch.com/industry-report/molecular-diagnostics-point-of-care-market

About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkedIn | Twitter | Blogs

Eric Lee
Emergen Research
+91 90210 91709
sales@emergenresearch.com
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire